131 related articles for article (PubMed ID: 24036132)
21. The N-terminal transactivation domain of the glucocorticoid receptor mediates apoptosis of human small cell lung cancer cells.
Singh N; Taylor K; Mjoli PB; Poolman T; Ray DW; Sommer P
Genes Chromosomes Cancer; 2014 Dec; 53(12):999-1007. PubMed ID: 25116573
[TBL] [Abstract][Full Text] [Related]
22. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.
Plummer HK; Dhar MS; Cekanova M; Schuller HM
BMC Cancer; 2005 Aug; 5():104. PubMed ID: 16109170
[TBL] [Abstract][Full Text] [Related]
23. TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.
Payapilly A; Guilbert R; Descamps T; White G; Magee P; Zhou C; Kerr A; Simpson KL; Blackhall F; Dive C; Malliri A
Cell Rep; 2021 Nov; 37(6):109979. PubMed ID: 34758330
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer.
Cao J; Song Y; Bi N; Shen J; Liu W; Fan J; Sun G; Tong T; He J; Shi Y; Zhang X; Lu N; He Y; Zhang H; Ma K; Luo X; Lv L; Deng H; Cheng J; Zhu J; Wang L; Zhan Q
Cancer Res; 2013 Jun; 73(11):3326-35. PubMed ID: 23592755
[TBL] [Abstract][Full Text] [Related]
26. In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability.
Santos AO; Pereira JP; Pedroso de Lima MC; Simões S; Moreira JN
Braz J Med Biol Res; 2010 Oct; 43(10):1001-9. PubMed ID: 20922271
[TBL] [Abstract][Full Text] [Related]
27. Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors.
Lam LT; Lin X; Faivre EJ; Yang Z; Huang X; Wilcox DM; Bellin RJ; Jin S; Tahir SK; Mitten M; Magoc T; Bhathena A; Kati WM; Albert DH; Shen Y; Uziel T
Mol Cancer Ther; 2017 Aug; 16(8):1511-1520. PubMed ID: 28468776
[TBL] [Abstract][Full Text] [Related]
28. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
[TBL] [Abstract][Full Text] [Related]
29. Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.
Hopkins-Donaldson S; Ziegler A; Kurtz S; Bigosch C; Kandioler D; Ludwig C; Zangemeister-Wittke U; Stahel R
Cell Death Differ; 2003 Mar; 10(3):356-64. PubMed ID: 12700635
[TBL] [Abstract][Full Text] [Related]
30. Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies.
Kedar R; Sabag O; Licthenstein M; Lorberboum-Galski H
Cancer; 2012 Dec; 118(24):6089-104. PubMed ID: 22692727
[TBL] [Abstract][Full Text] [Related]
31. Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis.
Walter RF; Werner R; Ting S; Vollbrecht C; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J; Mairinger FD
Oncotarget; 2015 Sep; 6(28):24690-8. PubMed ID: 26008974
[TBL] [Abstract][Full Text] [Related]
32. Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer.
Zhang Y; Wang JH; Lu Q; Wang YJ
Oncol Rep; 2012 Jan; 27(1):109-13. PubMed ID: 21971866
[TBL] [Abstract][Full Text] [Related]
33. Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
Bonner JA; Willey CD; Yang ES; Dobelbower MC; Sanford LL; Bright SJ; Buchsbaum DJ; Raisch KP
Radiother Oncol; 2011 Oct; 101(1):183-9. PubMed ID: 21722984
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
35. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
Ali MA; Rosati R; Pettit GR; Kalemkerian GP
Anticancer Res; 1998; 18(2A):1021-6. PubMed ID: 9615758
[TBL] [Abstract][Full Text] [Related]
36. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
Li J; Johnson TA; Hanson LA; Beer DG
Mol Carcinog; 1996 Aug; 16(4):213-20. PubMed ID: 8784464
[TBL] [Abstract][Full Text] [Related]
37. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D
Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.
Sun SY; Yue P; Zhou JY; Wang Y; Choi Kim HR; Lotan R; Wu GS
Biochem Biophys Res Commun; 2001 Jan; 280(3):788-97. PubMed ID: 11162590
[TBL] [Abstract][Full Text] [Related]
39. Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells.
Lu Y; Liu Y; Jiang J; Xi Z; Zhong N; Shi S; Wang J; Wei X
Oncol Rep; 2014 Jul; 32(1):243-9. PubMed ID: 24841948
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer.
Gaitan D; DeBold CR; Turney MK; Zhou P; Orth DN; Kovacs WJ
Mol Endocrinol; 1995 Sep; 9(9):1193-201. PubMed ID: 7491111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
